Literature DB >> 19041700

Anti-inflammatory, analgesic and wound healing activities of the leaves of Memecylon edule Roxb.

Somsak Nualkaew1, Kwanchai Rattanamanee, Suchitra Thongpraditchote, Yuwadee Wongkrajang, Adolf Nahrstedt.   

Abstract

AIM OF THE STUDY: To determine the anti-inflammatory, analgesic and antioxidant activities of the leaves of Memecylon edule Roxb. used traditionally in Thailand.
MATERIALS AND METHODS: Hexane, (Hex), ethyl acetate (EtOAc), methanol (MeOH) and 50% methanol (MeOH50) fractions of the dry leaves were tested in vitro for their interleukin-10 production; the most active fraction was further studied in vivo for its anti-inflammatory and analgesic activities using the ethylphenylpropiolate (EPP)-induced mouse ear edema and the writhing test with mice. All fractions except Hex were tested for their radical scavenging activity towards 1'-diphenyl-2-picrylhydrazyl radical (DPPH).
RESULTS: The EtOAc showed the highest stimulation for interleukin-10 production. In the EPP test, this fraction was significantly active 30 min after topical application at all doses used (0.5, 1.0, 2.0mg/ear); after 4h and at 1.0mg/ear EtOAc was slightly less active (inhibition 47.8%) than the reference, indomethacin, at the same dose (62.4%). At 200mg/kg orally, the EtOAc caused a significant inhibition of the writhing response by 56.6% which was like indomethacin at 10mg/kg. EtOAc, MeOH and MeOH50 exhibited radical scavenging activity. The order of IC(50) values was: ascorbic acid (9.1 microg/mL)>trolox (11.6 microg/mL)>MeOH (46.9 microg/mL)>MeOH50 (152.1 microg/mL)>EtOAc (1742.2 microg/mL).
CONCLUSION: The results provide support for the traditional use of Memecylon edule leaves in relieving inflammation and pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041700     DOI: 10.1016/j.jep.2008.10.034

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Anti-inflammatory and antinociceptive activities of the leaf methanol extract of Miconia minutiflora (Bonpl.) DC. and characterization of compounds by UPLC-DAD-QTOF-MS/MS.

Authors:  Aline Stamford S G Gatis-Carrazzoni; Fernanda Virgínia Barreto Mota; Tonny Cley Campos Leite; Tatiane Bezerra de Oliveira; Sandra Cabral da Silva; Isla Vanessa Alves Bastos; Maria Bernadete de Souza Maia; Pedro Silvino Pereira; Pedro Paulo Marcelino Neto; Earl Celestino de Oliveira Chagas; Tania Maria Sarmento Silva; Márcia Silva do Nascimento; Teresinha Gonçalves da Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-13       Impact factor: 3.000

2.  The medicinal plants of Myanmar.

Authors:  Robert A DeFilipps; Gary A Krupnick
Journal:  PhytoKeys       Date:  2018-06-28       Impact factor: 1.635

3.  Illustration of anti-rheumatic mechanism of rheumavedic capsule.

Authors:  Sumanth Meera; Nandeep Ramaiah; Narasimharaju Kalidindi
Journal:  Saudi Pharm J       Date:  2011-07-22       Impact factor: 4.330

4.  Memecylon edule leaf extract mediated green synthesis of silver and gold nanoparticles.

Authors:  Tamizhamudu Elavazhagan; Kantha D Arunachalam
Journal:  Int J Nanomedicine       Date:  2011-06-21

5.  In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.

Authors:  Permal Deo; Erandi Hewawasam; Aris Karakoulakis; David J Claudie; Robert Nelson; Bradley S Simpson; Nicholas M Smith; Susan J Semple
Journal:  BMC Complement Altern Med       Date:  2016-11-04       Impact factor: 3.659

6.  Antioxidant and Antiproliferative Potential of Bioactive Molecules Ursolic Acid and Thujone Isolated from Memecylon edule and Elaeagnus indica and Their Inhibitory Effect on Topoisomerase II by Molecular Docking Approach.

Authors:  Ramalingam Srinivasan; Arumugam Aruna; Jong Suk Lee; Myunghee Kim; Muthugounder Subramaniam Shivakumar; Devarajan Natarajan
Journal:  Biomed Res Int       Date:  2020-02-14       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.